Avalo Therapeutics (AVTX) Cash from Investing Activities (QoQ) (2016 - 2026)
Avalo Therapeutics (AVTX) Cash from Investing Activities (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,393.57% |
| Mar 31, 2026 | 962.27% |
| Dec 31, 2025 | 118.11% |
| Sep 30, 2025 | 81.29% |
| Sep 30, 2022 | 30.36% |
| Dec 31, 2021 | 86.42% |
| Mar 31, 2021 | 94.63% |
| Dec 31, 2020 | -520.63% |
| Sep 30, 2020 | -100.49% |
| Jun 30, 2020 | 1,126.14% |
| Mar 31, 2020 | -591.19% |
| Dec 31, 2019 | -3,459.31% |
| Sep 30, 2019 | 94.41% |
| Jun 30, 2019 | 45.20% |
| Mar 31, 2019 | 66.76% |
| Dec 31, 2018 | -135.91% |
| Sep 30, 2018 | 20,835.80% |
| Jun 30, 2018 | 65.11% |
| Mar 31, 2018 | 99.90% |
| Dec 31, 2017 | -305,349.46% |